J. Mark Brown

15.3k total citations · 2 hit papers
134 papers, 8.7k citations indexed

About

J. Mark Brown is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, J. Mark Brown has authored 134 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 40 papers in Surgery and 35 papers in Physiology. Recurrent topics in J. Mark Brown's work include Cholesterol and Lipid Metabolism (22 papers), Gut microbiota and health (20 papers) and Diet and metabolism studies (18 papers). J. Mark Brown is often cited by papers focused on Cholesterol and Lipid Metabolism (22 papers), Gut microbiota and health (20 papers) and Diet and metabolism studies (18 papers). J. Mark Brown collaborates with scholars based in United States, China and France. J. Mark Brown's co-authors include Stanley L. Hazen, Lawrence L. Rudel, Michael McIntosh, Mark A. McPeek, Zeneng Wang, Aldons J. Lusis, R. G. Harrison, Olle Pellmyr, John N. Thompson and Jennifer A. Buffa and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

J. Mark Brown

131 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

2016 1.4k citations Jennifer A. Buffa, Zeneng Wang et al. profile →
Microbial modulation of cardiovascular disease

2018 321 citations J. Mark Brown, Stanley L. Hazen profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mark Brown United States	50	4.1k	2.5k	1.4k	1.3k	924	134	8.7k
Martha Vaughan United States	66	7.0k 1.7×	2.5k 1.0×	1.1k 0.7×	642 0.5×	1.1k 1.2×	295	14.0k
Martin S. Obin United States	45	4.3k 1.0×	4.9k 2.0×	915 0.6×	4.0k 3.1×	1.6k 1.7×	82	12.2k
Mary‐Ellen Harper Canada	67	8.7k 2.1×	7.6k 3.1×	856 0.6×	2.8k 2.1×	847 0.9×	243	18.6k
Haider Raza United Arab Emirates	38	6.9k 1.7×	1.2k 0.5×	563 0.4×	840 0.6×	622 0.7×	114	13.4k
Stephen A. Smith United States	54	4.0k 1.0×	1.7k 0.7×	1.1k 0.7×	1.8k 1.4×	431 0.5×	308	11.5k
F. Thomas Wunderlich Germany	60	5.2k 1.3×	2.4k 1.0×	1.1k 0.7×	2.3k 1.7×	298 0.3×	243	13.5k
David J. Orlicky United States	49	2.9k 0.7×	1.3k 0.5×	685 0.5×	1.5k 1.2×	927 1.0×	217	7.5k
Annie John United Arab Emirates	26	5.4k 1.3×	955 0.4×	482 0.3×	729 0.6×	404 0.4×	61	11.0k
Miguel P. Soares Portugal	67	11.2k 2.7×	1.2k 0.5×	2.0k 1.4×	1.4k 1.1×	854 0.9×	149	18.0k
Yoshinori Moriyama Japan	62	6.6k 1.6×	1.2k 0.5×	956 0.7×	1.6k 1.2×	1.1k 1.2×	274	13.7k

Countries citing papers authored by J. Mark Brown

Since Specialization

Citations

This map shows the geographic impact of J. Mark Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Brown more than expected).

Fields of papers citing papers by J. Mark Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Brown. The network helps show where J. Mark Brown may publish in the future.

Co-authorship network of co-authors of J. Mark Brown

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Brown. A scholar is included among the top collaborators of J. Mark Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Brown. J. Mark Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beveridge, Claire, Yi Qin, Prashanthi N. Thota, et al.. (2025). An Esophageal Luminal Diameter of 16 mm Predicts Dysphagia Resolution in Eosinophilic Esophagitis. Digestive Diseases and Sciences. 70(5). 1824–1831.

Banerjee, Rakhee, Chase J. Wehrle, Zeneng Wang, et al.. (2024). Circulating Gut Microbe-Derived Metabolites Are Associated with Hepatocellular Carcinoma. Biomedicines. 12(9). 1946–1946. 4 indexed citations

West, Xiaoxia Z., Detao Gao, Rakhilya Murtazina, et al.. (2024). TLR2 regulates hair follicle cycle and regeneration via BMP signaling. eLife. 12. 5 indexed citations

Saha, Prasenjit Prasad, Valentin Gogonea, Wendy E. Sweet, et al.. (2024). Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors. Nature Communications. 15(1). 6696–6696. 13 indexed citations

Massey, William J., Pranab K. Mukherjee, Quang Tam Nguyen, et al.. (2024). Sa1881 MICROBIAL TRIMETHYLAMINE EXERTS PROFIBROTIC PROPERTIES IN IBD - IMPLICATIONS FOR NOVEL ANTI-FIBROTIC THERAPIES. Gastroenterology. 166(5). S–563. 1 indexed citations

Massey, William J., Pranab K. Mukherjee, Quang Tam Nguyen, et al.. (2024). THE PATHOGENIC ROLE OF MICROBIAL TRIMETHYLAMINE IN IBD ASSOCIATED INTESTINAL FIBROSIS. Gastroenterology. 166(3). S87–S88. 1 indexed citations

Ricciardi, Natalie, Farzaneh Modarresi, Ines Lohse, et al.. (2023). Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models. Molecular Neurobiology. 60(8). 4811–4827. 4 indexed citations

West, Xiaoxia Z., Detao Gao, Rakhilya Murtazina, et al.. (2023). TLR2 regulates hair follicle cycle and regeneration via BMP signaling. eLife. 12. 4 indexed citations

Massey, William J., Venkateshwari Varadharajan, Rakhee Banerjee, et al.. (2023). MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis. Journal of Lipid Research. 64(4). 100349–100349. 9 indexed citations

10.

Shakya, Sajina, Anthony D. Gromovsky, James S. Hale, et al.. (2021). Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches. Acta Neuropathologica Communications. 9(1). 81 indexed citations

11.

Tan, Sze Kiat, Iqbal Mahmud, Flavia Fontanesi, et al.. (2021). Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance. Cancer Discovery. 11(8). 2072–2093. 78 indexed citations

12.

Silver, Daniel J., Gustavo Roversi, Sabrina Wang, et al.. (2021). Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma. Journal of Clinical Investigation. 131(17). 39 indexed citations

13.

Brubaker, Gregory, Jennifer Major, Chase Neumann, et al.. (2020). Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice. Journal of Biological Chemistry. 295(24). 8252–8261. 31 indexed citations

14.

Pathak, Preeti, Robert N. Helsley, Amanda L. Brown, et al.. (2020). Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism. American Journal of Physiology-Heart and Circulatory Physiology. 318(6). H1474–H1486. 65 indexed citations

15.

Bernal‐Chico, Ana, Raffaela Cipriani, Asier Ruiz, et al.. (2018). Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology. 141. 181–191. 16 indexed citations

16.

Gliniak, Christy, J. Mark Brown, & Noa Noy. (2017). The retinol-binding protein receptor STRA6 regulates diurnal insulin responses. Journal of Biological Chemistry. 292(36). 15080–15093. 24 indexed citations

17.

Janssen, Aafke W. F., Tom Houben, Saeed Katiraei, et al.. (2017). Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. Journal of Lipid Research. 58(7). 1399–1416. 97 indexed citations

18.

Arif, Abul, Fulvia Terenzi, Alka A. Potdar, et al.. (2017). EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice. Nature. 542(7641). 357–361. 98 indexed citations

19.

Alger, Heather M., J. Mark Brown, Janet K. Sawyer, et al.. (2010). Inhibition of Acyl-Coenzyme A:Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization. Journal of Biological Chemistry. 285(19). 14267–14274. 67 indexed citations

20.

Brown, J. Mark, Jenna L. Betters, Caleb C. Lord, et al.. (2010). CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. Journal of Lipid Research. 51(11). 3306–3315. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact